Article
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Feb 2018
Caddeo A, Mancina R M, Pirazzi C, Russo C, Sasidharan K, Sandstedt J, Maurotti S, Montalcini T, Pujia A, Leren T P, Romeo S, Pingitore P
Abstract excerpt
BACKGROUND AND AIMS: Type I hyperlipoproteinemia, also known as familial chylomicronemia syndrome (FCS), is a rare autosomal recessive disorder caused by variants in LPL, APOC2, APOA5, LMF1 or GPIHBP1 genes. The aim of this study was to identify novel variants in the LPL gene causing lipoprotein lipase deficiency and to understand the molecular mechanisms. METHODS AND RESULTS: A total of 3 individuals with severe...
Read the complete abstract on PubMedTopics
- Adult
- Aged
- Female
- Genetic Predisposition to Disease
- HEK293 Cells
- Heterozygote
